Oncofertility: A Review of Recent Advances in Woman Fertility Preservation for Adolescents and Young Adults with Cancer View PDF

The field of oncofertility has experienced significant growth over recent years, driven by advances in medical science, increased awareness of fertility issues among young cancer patients, and the development of international collaborative efforts [1-8]. This review summarizes current knowledge and recent developments in fertility preservation strategies for adolescents and young adults with cancer, emphasizing the multidisciplinary nature of the field, the technological innovations, and the challenges related to access, decision-making, and ethical considerations. One of the foundational aspects of oncofertility is the establishment of a global community of practice, which has facilitated the dissemination of knowledge, resources, and best practices worldwide [9-14]. Ataman et al. [9] highlighted how the oncofertility consortium has expanded its scope beyond malignant conditions to include nonmalignant diseases threatening fertility. The creation of translated and adaptable materials, along with the development of local programs of excellence, has accelerated research and improved clinical practice globally. This collaborative approach underscores the importance of shared resources and standardized guidelines in advancing fertility preservation options for young cancer patients.

Technological advances in fertility preservation techniques are central to recent progress [15-21]. Dolmans et al. [22] focused on ovarian tissue cryopreservation, which remains the only viable option for prepubertal girls and young women requiring immediate chemotherapy. The review discusses the challenges associated with freezing and transplanting ovarian tissue, as well as emerging approaches such as artificial ovaries. Similarly, Zhao et al. [23] and McClam and Xiao [24] provide comprehensive overviews of oocyte and embryo cryopreservation, ovarian suppression, ovarian transposition, and in vitro maturation, emphasizing the multidisciplinary efforts to optimize these techniques. These advances have expanded the repertoire of fertility preservation options, allowing tailored approaches based on patient age, cancer type, and urgency of treatment.

In male patients, recent research has focused on sperm banking and other reproductive preservation methods [25-27]. Bîc? et al. [28] review the latest approaches in pediatric and adolescent male oncofertility, including counseling, sperm banking, and emerging scientific techniques. The emphasis on early counseling and intervention is crucial, given the gonadotoxic effects of chemotherapy and radiation. Similarly, Sandheinrich et al. [29] examine factors influencing decision-making among young males, highlighting the importance of understanding patient perspectives to improve uptake of fertility preservation services. For female patients, gonadotoxicity from chemoradiotherapy remains a significant concern. Vo and Kawamura [30] summarize the current understanding of treatment-related gonadotoxicity and discuss therapeutic approaches, controversies, and future perspectives. They emphasize that advances in early detection and targeted therapies have improved survival rates but also necessitate effective fertility preservation strategies. Henry et al. [19] analyze recent literature on the therapeutic strategies for female fertility preservation, including ovarian suppression and tissue cryopreservation, underscoring the importance of individualized treatment plans.

Decision-making and patient-centered care are critical components of oncofertility [31-35]. Gonçalves [36] addresses decisional regret among women who have undergone fertility preservation, emphasizing the psychological impact of fertility preservation decisions. Levin et al. [37] further explore financial concerns, noting that the cost of fertility preservation services can be a significant barrier for adolescents and young adults, and advocate for policy changes to improve coverage and reduce disparities. Turner et al. [38] highlight disparities in access to fertility preservation care in the United States, calling for enhanced education, advocacy, and equitable resource distribution. The importance of early counseling and communication is reinforced by Maeda [39], who notes that information provision to pediatric cancer patients remains insufficient despite increased availability of fertility preservation options. The development of clinical practice guidelines, as described by Kaur et al. [40], aims to standardize care and ensure that young patients receive appropriate counseling and access to fertility preservation services across different regions and healthcare systems.

Ethical considerations and patient perspectives are also integral to the field. Paw?owski et al. [41] examine healthcare system factors and attitudes of patients and caregivers, emphasizing the need for ethically sound practices and culturally sensitive counseling. Decision regret and long-term satisfaction are areas of ongoing research, with systematic reviews by Kuntz et al. [42] and others exploring determinants of regret and decision-making processes. Finally, the integration of oncofertility into comprehensive cancer care is exemplified by initiatives like the Australian Youth Cancer Service, which monitors and improves care quality across multiple domains, including fertility preservation [43]. Such programs demonstrate the importance of multidisciplinary, patient-centered approaches that address not only the medical but also the psychosocial and financial needs of young cancer survivors.

In summary, recent advances in oncofertility for adolescents and young adults with cancer encompass technological innovations, international collaboration, and a growing emphasis on personalized, ethically sound, and accessible care. While significant progress has been made, ongoing challenges related to disparities, decision-making, and long-term outcomes remain. Continued research, policy development, and global cooperation are essential to ensure that all young cancer patients have equitable access to fertility preservation options and can achieve their reproductive goals post-treatment.